LogicBio Therapeutics, Inc. (LOGC) [Rocket]

In millions, except per share items	Dec-31-21	Dec-31-20	Dec-31-19	Dec-31-18	Dec-31-17	Dec-31-16
	10-K	10-K	10-K	10-K	10-K	S-1/A
Revenues [+]	5.4	3.5	0.0	0.0	0.0	2.0
Royalties						2.0
Revenue growth	56.6%				-100.0%
Cost of goods sold	0.0	0.0	0.0	0.0	0.0	3.4
Gross profit	5.4	3.5	0.0	0.0	0.0	-1.4
Gross margin	100.0%	100.0%				-67.6%
Selling, general and administrative [+]	16.2	12.2	10.4	6.9	2.3	1.4
General and administrative	16.2	12.2	10.4	6.9	2.3	1.4
Research and development	28.2	22.8	30.7	11.1	3.6
Other operating expenses						0.7
EBITDA [+]	-38.4	-31.0	-40.8	-17.9	-5.8	-3.4
EBITDA growth	23.6%	-23.8%	128.3%	207.2%	71.6%
EBITDA margin	-709.0%	-898.6%				-166.8%
Depreciation and amortization	0.6	0.5	0.3	0.1	0.0	0.0
EBIT [+]	-39.0	-31.5	-41.0	-17.9	-5.9	-3.4
EBIT growth	23.7%	-23.2%	128.7%	206.5%	72.0%
EBIT margin	-720.6%	-912.3%				-167.6%
Interest expense, net [+]	1.1	1.1	0.5	0.0	-0.1	0.0
Interest expense	1.1	1.1	0.5	0.0		0.0
Interest income					0.1
Other income (expense), net	0.0	0.2	1.5	0.4	0.1	0.0
Pre-tax income	-40.1	-32.4	-40.1	-17.5	-5.7	-3.4
Income taxes	0.0	0.2	0.0	0.1	0.1	0.0
Tax rate	0.1%
Net income	-40.0	-32.6	-40.1	-17.6	-5.8	-3.4
Net margin	-739.9%	-944.4%				-168.9%

Basic EPS [+]	($1.24)	($1.29)	($1.78)	($3.04)	($4.15)	($4,037.40)
Growth	-3.9%	-27.6%	-41.5%	-26.9%	-99.9%
Diluted EPS [+]	($1.24)	($1.29)	($1.78)	($3.04)	($4.15)	($4,037.40)
Growth	-3.9%	-27.6%	-41.5%	-26.9%	-99.9%

Shares outstanding (basic) [+]	32.4	25.4	22.6	5.8	1.4	0.0
Growth	27.6%	12.2%	289.6%	315.8%	164244.0%
Shares outstanding (diluted) [+]	32.4	25.4	22.6	5.8	1.4	0.0
Growth	27.6%	12.2%	289.6%	315.8%	164244.0%

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.